Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CholestaGel non-absorbed cholesterol trapping agent data

GELX announced that preliminary analysis of two Phase II trials showed that once daily

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE